18 matches for your search in the start-up spotlight
rss
Better generate, manage and analyze histopathology data on a large scale
28-Jan-2025
LIMAA Technologies, an innovative deep-tech startup in the field of medical technology solutions, is proud to announce a strategic partnership with Labor Becker, one of Germany’s largest and owner-managed diagnostic laboratories. The collaboration is set to accelerate the development of LIMAA's ...
Teams from informatics, environmental engineering and medicine
04-Dec-2024
An AI-controlled construction robot, a CO2 conversion process and a test to detect head and neck tumors: These three promising start-up ideas from researchers are the latest winners of the TUM IDEAward. Which ideas can be turned into successful products? What start-up team is addressing the ...
Precise cancer classification of subtypes that are otherwise difficult or impossible to distinguish
16-Jul-2024
Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor ...
Two start-ups are already working to bring these findings closer to public fruition
18-Jun-2024
Dr. Oren Moscovitz has been awarded €25,000 by the Max Planck Society for his promising research toward treatments and non-invasive diagnostics for cancer, which could potentially reduce overall cancer-related deaths. Moscovitz and his team exploit unique sugar patterns found on cancer cells and ...
Cyber Valley Community is advancing diagnostics for the future: Its goal is to create an innovative spin-off from the project after the funding term has ended
16-Apr-2024
Pioneering cutting-edge diagnostic systems for the detection of complex diseases: Cyber Valley is pleased to announce it has awarded funding of 500K EUR to the CELL’n’ROLL team through the 2023 Cyber Valley Innovation Fellowship program, funded by the Carl-Zeiss-Stiftung. CELL’n’ROLL aims to ...
12-Sep-2023
The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. Since 2022, this test has also been ...
hema.to raises €3.6M
20-Jul-2023
hema.to’s mission is to make the clinical analysis of blood data — called cytometry — automated and fully objective to enable personalization of treatment to every person’s unique immune system. Currently, even for skilled laboratory personnel, cytometry analysis is a laborious process that has a ...
Identify tumour margins directly in the surgery room: Refined Laser Systems raises €2.7m
30-Jan-2023
Refined Laser Systems, a dynamic biophotonics company specialised in pioneering laser systems for SRS-microscopy and quantum technology, today announces a Seed funding round of €2.7 million led by High-Tech Gründerfonds and APEX Ventures, along with NRW.BANK, Onsight Ventures and Papst Venture ...
23-Sep-2022
Liquid biopsy cancer testing is one of the most transformational innovations in healthcare for the next decade, directly unlocking better outcomes for patients. Swiss techbio companyHedera Dx, founded in 2021 by veteran healthcare entrepreneurs and executives, will be launching this fall a ...
Study on Head-and-Neck tumors aims to demonstrate that a diagnostic method can reliably and early detect malignant tumors using non-invasive saliva samples
23-Apr-2021
The biotechnology company oncgnostics GmbH is researching a method for diagnosing Head-and-Neck tumors together with the clinical department for general ENT at the Medical University of Graz as part of the “OroCa-Graz” study. 550,000 people worldwide develop carcinomas of this type every year. As ...
